Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596579 · ClinicalTrials.gov registry record
SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 1,135
- Enrollment target
NCT04596579: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04596579 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 1,135 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04596579 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 1,135 participants
- Enrollment target
Study Summary
The overall goal of this study is to understand the immune response (IgG) to SARS-CoV-2 to fill critical knowledge gaps in the natural history of this virus and to inform the development of future infection mitigation efforts. The study team aims to assess the prevalence of circulating IgG antibodies to SARS-CoV-2 and the factors associated with sero-prevalence. These data will be used to estimate the total population that has been exposed to the virus (asymptomatic and symptomatic), the proportion of the population that may be protected by natural immunity, and the proportion that is susceptible. Data obtained from this research will be shared with the Florida Department of Health.
Primary Outcome
All participants who respond to study invitation letter will be tested for SARS-CoV-2 antibodies after completing a web-based questionnaire.
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2 Antibody Analysis
- DIAGNOSTIC_TEST Weck-cel Swab Collection
- BEHAVIORAL Web Based Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,135 participants |
| Start Date | 2020-10-17 |
| Est. Completion | 2021-07-25 |
What the finished NCT04596579 record still lists
NCT04596579 is an observational study that tracks outcomes without assigning an intervention. Its 1,135 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which SARS-CoV-2 Antibody Analysis is the first listed.
NCT04596579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04596579 about?
NCT04596579 is a clinical study titled "SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida". The overall goal of this study is to understand the immune response (IgG) to SARS-CoV-2 to fill critical knowledge gaps in the natural history of this virus and to inform the development of future infection mitigation efforts. The study team aims to assess the prevalence of circulating IgG antibodie...
What is the current status of trial NCT04596579?
This trial is currently completed. The enrollment target is 1,135 participants. The study started on 2020-10-17. Estimated completion is 2021-07-25.
What interventions are being tested in trial NCT04596579?
The interventions under investigation include: SARS-CoV-2 Antibody Analysis (DIAGNOSTIC_TEST), Weck-cel Swab Collection (DIAGNOSTIC_TEST), Web Based Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT04596579?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI